Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.30 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.30 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
| ▸ | BRD2 | P25440 | 1/20 | 0.30 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17952263 | 0.91 | KDM4E (0.34) | GAAKDM4EALDH1A1GLACYP11B1 | |
| SCHEMBL17952339 | 0.91 | KDM4E (0.34) | GAAKDM4EALDH1A1GLACYP11B1 | |
| SCHEMBL17952185 | 0.86 | SMN1; SMN2 (0.36) | GAAKDM4EALDH1A1GLACYP11B1 | |
| SCHEMBL17952277 | 0.86 | ALDH1A1 (0.36) | GAAKDM4EALDH1A1GLACYP11B1 | |
| SCHEMBL17952113 | 0.86 | TSHR (0.36) | GAAKDM4EALDH1A1GLACYP1A2 | |
| SCHEMBL17952270 | 0.85 | ALDH1A1 (0.33) | GAAKDM4EALDH1A1GLACYP1A2 | |
| SCHEMBL17952392 | 0.85 | ALDH1A1 (0.31) | GAAKDM4EALDH1A1GLACYP1A2 | |
| SCHEMBL17952319 | 0.85 | ALDH1A1 (0.37) | GAAKDM4EALDH1A1GLACYP11B1 | |
| SCHEMBL17952284 | 0.84 | ALDH1A1 (0.35) | GAAKDM4EALDH1A1GLAGRIA2 | |
| SCHEMBL17952267 | 0.84 | ALDH1A1 (0.36) | GAAKDM4EALDH1A1GLACYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10418569-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-09-17 | — | — | US | disclosed |
| US-20160218303-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10418569-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, OSBP2 | GAA 2911/4885KDM4E 4426/4885ALDH1A1 1620/4885 |
| US-20160218303-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OSBP2 | GAA 2911/4885KDM4E 4426/4885ALDH1A1 1620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.